Trials

University Hospitals Birmingham NHS Foundation Trust is a regional and national centre for specialist clinical services.

It is home to some of the country’s leading clinical research institutions, and is dedicated to developing and implementing groundbreaking treatments, technologies and techniques.

• Understanding the challenges and impact of parenting with epilepsy: A focus on mothers

  View Trial

• RAPSODI GD

  Remote assessment of Parkinsonism supporting ongoing development of interventions in Gaucher’s disease

  View Trial

• Review of renal dysfunction in recipients of orthotopic liver allografts in the UK

  View Trial

• REQUITE

  Validating predictive models and biomarkers of radiotherapy toxicity to reduce side-effects and improve quality-of-life in cancer survivors

  View Trial

• Phase 4 Placebo Controlled Study of the Impact of Apremilast on Quality of Life Efficacy and Safety in Subjects with Manifestations of Plaque Psoriasis and Impaired Quality of Life

  View Trial

• A PROSPECTIVE OBSERVATIONAL REGISTRY OF PATIENTS WITH FABRY DISEASE

  View Trial

• EczTend

  Long-term extension trial in subjects with atopic dermatitis who participated in previous tralokinumab trials – ECZTEND

  View Trial

• TIME

  A study of transient epileptic amnesia accelerated forgetting and focal retrograde amnesia in temporal lobe epilepsy

  View Trial

• SUNRISE

  A randomized double-blind multicenter study assessing short (16 weeks) and long-term efficacy (up to 1 year) safety and tolerability of 2 subcutaneous secukinumab dose regimens in adult patients with moderate to severe hidradenitis suppurativa (SUNRISE)

  View Trial

• A Long-Term Follow-up Study to Evaluate the Safety and Efficacy of Adeno-Associated Virus (AAV) Serotype 8 (AAV8)-Mediated Gene Transfer of Human Ornithine Transcarbamylase (OTC) in Adults with Late-Onset OTC Deficiency

  View Trial